Department of Health Services Research & Policy, London School of Hygiene & Tropical Medicine, London, UK.
Seizure. 2012 Apr;21(3):205-10. doi: 10.1016/j.seizure.2011.12.012. Epub 2012 Jan 28.
Despite the common occurrence of intellectual disability (ID) in people with epilepsy, most studies of the cost of epilepsy have focussed primarily or exclusively on people without ID. This paper estimates the costs of supporting people with epilepsy and ID.
Prospective resource use and outcome data were collected on 91 participants from the east of England for seven months. Multivariate analysis was used to investigate the relationship between costs and patient and healthcare provider characteristics.
Mean health care costs relating to epilepsy or ID were £2800 (3500 Euros, 5200 USD) p.a. Modelling suggests costs are lower for patients with more severe ID (p=0.014); and higher for patients managed by a consultant neurologist (p=0.037).
Our findings support limited evidence from the literature of increased epilepsy costs in people with ID. Patterns of expenditure suggest clinical variation in the treatment of epilepsy according to the severity of ID, particularly in the absence of management by a consultant neurologist.
尽管智力残疾（ID）在癫痫患者中较为常见，但大多数关于癫痫成本的研究主要或专门针对无 ID 的患者。本文旨在评估支持癫痫合并 ID 患者的成本。
前瞻性收集了来自英格兰东部的 91 名参与者的资源使用和结局数据，为期 7 个月。采用多元分析方法调查了成本与患者和医疗服务提供者特征之间的关系。
每年与癫痫或 ID 相关的平均医疗保健费用为 2800 英镑（3500 欧元，5200 美元）。模型表明，ID 程度越严重的患者成本越低（p=0.014）；而由神经科顾问管理的患者成本更高（p=0.037）。
我们的研究结果支持文献中有限的证据，即 ID 患者的癫痫成本增加。支出模式表明，根据 ID 的严重程度，癫痫的治疗存在临床差异，特别是在没有神经科顾问管理的情况下。
